BACKGROUND: Significant safety concerns remain surrounding the use of nonsteroidal anti-inflammatory drugs (NSAIDs) following gastrointestinal surgery, leading to wide variation in their use. This study aimed to determine the safety profile of NSAIDs after major gastrointestinal surgery. METHODS: Consecutive patients undergoing elective or emergency abdominal surgery with a minimum one-night stay during a 3-month study period were eligible for inclusion. The administration of any NSAID within 3 days following surgery was the main independent variable. The primary outcome measure was the 30-day postoperative major complication rate, as defined by the Clavien-Dindo classification (Clavien-Dindo III-V). Propensity matching with multivariable logistic regression was used to produce odds ratios (OR) and 95 % confidence intervals. RESULTS: From 9264 patients, 23.9 % (n = 2212) received postoperative NSAIDs. The overall major complication rate was 11.5 % (n = 1067). Following propensity matching and adjustment, use of NSAIDs were not significantly associated with any increase in major complications (OR 0.90, 0.60-1.34, p = 0.560). CONCLUSIONS: Early use of postoperative NSAIDs was not associated with an increase in major complications following gastrointestinal surgery.
BACKGROUND: Significant safety concerns remain surrounding the use of nonsteroidal anti-inflammatory drugs (NSAIDs) following gastrointestinal surgery, leading to wide variation in their use. This study aimed to determine the safety profile of NSAIDs after major gastrointestinal surgery. METHODS: Consecutive patients undergoing elective or emergency abdominal surgery with a minimum one-night stay during a 3-month study period were eligible for inclusion. The administration of any NSAID within 3 days following surgery was the main independent variable. The primary outcome measure was the 30-day postoperative major complication rate, as defined by the Clavien-Dindo classification (Clavien-Dindo III-V). Propensity matching with multivariable logistic regression was used to produce odds ratios (OR) and 95 % confidence intervals. RESULTS: From 9264 patients, 23.9 % (n = 2212) received postoperative NSAIDs. The overall major complication rate was 11.5 % (n = 1067). Following propensity matching and adjustment, use of NSAIDs were not significantly associated with any increase in major complications (OR 0.90, 0.60-1.34, p = 0.560). CONCLUSIONS: Early use of postoperative NSAIDs was not associated with an increase in major complications following gastrointestinal surgery.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: John Rose; Thomas G Weiser; Phil Hider; Leona Wilson; Russell L Gruen; Stephen W Bickler Journal: Lancet Glob Health Date: 2015-04-27 Impact factor: 26.763
Authors: Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown Journal: Lancet Date: 2005 May 14-20 Impact factor: 79.321
Authors: D A Wattchow; D De Fontgalland; P A Bampton; P L Leach; K McLaughlin; M Costa Journal: Aliment Pharmacol Ther Date: 2009-08-20 Impact factor: 8.171
Authors: Azra Bihorac; Sinan Yavas; Sophie Subbiah; Charles E Hobson; Jesse D Schold; Andrea Gabrielli; A Joseph Layon; Mark S Segal Journal: Ann Surg Date: 2009-05 Impact factor: 12.969
Authors: Matthew D Neal; Joshua B Brown; Ernest E Moore; Joseph Cuschieri; Ronald V Maier; Joseph P Minei; Timothy R Billiar; Andrew B Peitzman; Mitchell J Cohen; Jason L Sperry Journal: Ann Surg Date: 2014-08 Impact factor: 12.969
Authors: Stephen J Chapman; James C D Glasbey; Chetan Khatri; Michael Kelly; Dmitri Nepogodiev; Aneel Bhangu; J Edward F Fitzgerald Journal: BMC Med Educ Date: 2015-03-13 Impact factor: 2.463
Authors: Michael McFarlane; Neeraj Bhala; Louise China; Laith Alrubaiy; Fergus Chedgy; Benjamin R Disney; Adam D Farmer; Edward Fogden; Gareth Sadler; Mark A Hull; John McLaughlin; Howard Ellison; Julie Solomon; Matthew James Brookes Journal: Frontline Gastroenterol Date: 2018-06-19
Authors: Christoph A Fink; Mirco Friedrich; Pia-Elena Frey; Lukas Rädeker; Alexander Leuck; Thomas Bruckner; Manuel Feisst; Solveig Tenckhoff; Christina Klose; Colette Dörr-Harim; Jens Neudecker; André L Mihaljevic Journal: BMC Surg Date: 2018-10-29 Impact factor: 2.102
Authors: Marius Schwab; Niall Brindl; Alexander Studier-Fischer; Thomas Tu; Julia Gsenger; Max Pilgrim; Mirco Friedrich; Pia-Elena Frey; Christina Achilles; Alexander Leuck; Thore Bürgel; Manuel Feisst; Christina Klose; Solveig Tenckhoff; Colette Dörr-Harim; André L Mihaljevic Journal: Trials Date: 2020-03-23 Impact factor: 2.279